Cargando…

Ad-p53 enhances the sensitivity of triple-negative breast cancer MDA-MB-468 cells to the EGFR inhibitor gefitinib

Triple-negative breast cancer (TNBC) accounts for 20% of all molecular subtypes of breast cancer. Neither endocrine nor anti-HER2 molecular targeting treatment yield promising results. At present, epidermal growth factor receptor (EGFR) inhibitor, as a single agent, is unable to obtain encouraging r...

Descripción completa

Detalles Bibliográficos
Autores principales:	WANG, XINZHAO, SONG, HONGKUAN, YU, QIAN, LIU, QI, WANG, LEILEI, LIU, ZHAOYUN, YU, ZHIYONG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306269/ https://www.ncbi.nlm.nih.gov/pubmed/25501339 http://dx.doi.org/10.3892/or.2014.3665

Ejemplares similares

Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib
por: Song, Xiang, et al.
Publicado: (2020)

PRIMA-1(MET) Does Not Restore Vitamin D Sensitivity to MDA-MB-231 and MDA-MB-468 Triple-Negative Breast Cancer Cells
por: Kotob, Shadi N., et al.
Publicado: (2023)

Therapeutic Potential of Albumin Nanoparticles Encapsulated Visnagin in MDA-MB-468 Triple-Negative Breast Cancer Cells
por: Alsrhani, Abdullah, et al.
Publicado: (2023)

Autophagy inhibitor facilitates gefitinib sensitivity in vitro and in vivo by activating mitochondrial apoptosis in triple negative breast cancer
por: Liu, Zhaoyun, et al.
Publicado: (2017)

Pyrazole Derivatives Induce Apoptosis via ROS Generation in the Triple Negative Breast Cancer Cells, MDA-MB-468
por: Ashourpour, Maryam, et al.
Publicado: (2021)

β-Caryophyllene Counteracts Chemoresistance Induced by Cigarette Smoke in Triple-Negative Breast Cancer MDA-MB-468 Cells
por: Di Sotto, Antonella, et al.
Publicado: (2022)

Sericin inhibits MDA-MB-468 cell proliferation via the PI3K/Akt pathway in triple-negative breast cancer
por: Niu, Lin, et al.
Publicado: (2021)

Effect of apigenin on whole transcriptome profile of TNFα-activated MDA-MB-468 triple negative breast cancer cells
por: Bauer, David, et al.
Publicado: (2020)

Targeted therapy of triple negative MDA-MB-468 breast cancer with curcumin delivered by epidermal growth factor-conjugated phospholipid nanoparticles
por: Jung, Kyung-Ho, et al.
Publicado: (2018)

Evaluation of MDA-MB-468 Cell Culture Media Analysis in Predicting Triple-Negative Breast Cancer Patient Sera Metabolic Profiles
por: Wojtowicz, Wojciech, et al.
Publicado: (2020)

Epigenetic Regulation of CDH1 Is Altered after HOXB7-Silencing in MDA-MB-468 Triple-Negative Breast Cancer Cells
por: Paço, Ana, et al.
Publicado: (2021)

MicroRNA-449a inhibits cell proliferation and migration by regulating mutant p53 in MDA-MB-468 cells
por: Huang, Guangcheng, et al.
Publicado: (2021)

Phytochemistry and Cytotoxic Activity of Aquilaria crassna Pericarp on MDA-MB-468 Cell Lines
por: Nguyen, Thao Thi Thu, et al.
Publicado: (2023)

Metabolic changes associated with methionine stress sensitivity in MDA-MB-468 breast cancer cells
por: Borrego, Stacey L., et al.
Publicado: (2016)

Role of Caryophyllane Sesquiterpenes in the Entourage Effect of Felina 32 Hemp Inflorescence Phytocomplex in Triple Negative MDA-MB-468 Breast Cancer Cells
por: Di Giacomo, Silvia, et al.
Publicado: (2021)

YC-1 exerts inhibitory effects on MDA-MB-468 breast cancer cells by targeting EGFR in vitro and in vivo under normoxic condition
por: Cheng, Ying, et al.
Publicado: (2012)

Selective regain of egfr gene copies in CD44(+)/CD24(-/low )breast cancer cellular model MDA-MB-468
por: Agelopoulos, Konstantin, et al.
Publicado: (2010)

The growth inhibitory effects of cadmium and copper on the MDA-MB468 human breast cancer cells
por: Panjehpour, Mojtaba, et al.
Publicado: (2010)

Anticancer effect of silibinin on the xenograft model using MDA-MB-468 breast cancer cells
por: Kil, Won Ho, et al.
Publicado: (2014)

Optimal Electroporation Condition for Small Interfering RNA Transfection into MDA-MB-468 Cell Line
por: Arabsolghar, Rita, et al.
Publicado: (2012)

Antibacterial Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Cytotoxic Effect against MDA-MB-468 and MDA-MB-231 Breast Cancer Cell Lines
por: Vargas Casanova, Yerly, et al.
Publicado: (2017)

Silencing of Nucleostemin by siRNA Induces Apoptosis in MCF-7 and MDA-MB-468 Cell Lines
por: Moudi, Mahdiyeh, et al.
Publicado: (2020)

Overexpressing modified human TRβ1 suppresses the proliferation of breast cancer MDA-MB-468 cells
por: Peng, Xiaoxiang, et al.
Publicado: (2018)

Anticancer Properties of Novel Rhenium Pentylcarbanato Compounds against MDA-MB-468(HTB-132) Triple Node Negative Human Breast Cancer Cell Lines
por: Parson, Carl, et al.
Publicado: (2015)

TP53 Binding to BRCA1 and RAD51 in MCF7 and MDA-MB-468 Breast Cancer Cell Lines In vivo and In vitro
por: Rasti, Mozhgan, et al.
Publicado: (2015)

Synthesis, Crystal Study, and Anti-Proliferative Activity of Some 2-Benzimidazolylthioacetophenones towards Triple-Negative Breast Cancer MDA-MB-468 Cells as Apoptosis-Inducing Agents
por: Abdel-Aziz, Hatem A., et al.
Publicado: (2016)

Mitochondria-targeted half-sandwich iridium(iii)-Cp*-arylimidazophenanthroline complexes as antiproliferative and bioimaging agents against triple negative breast cancer cells MDA-MB-468
por: Mondal, Ashaparna, et al.
Publicado: (2022)

Cytotoxicity of different extracts of arial parts of Ziziphus spina-christi on Hela and MDA-MB-468 tumor cells
por: Jafarian, Abbas, et al.
Publicado: (2014)

ChIP-chip data for identifying target genes and consensus binding sequences of mutant p53 in MDA-MB-468 breast cancer cells
por: Le, Mai Nhu Uyen, et al.
Publicado: (2023)

Lipid remodeling in response to methionine stress in MDA-MBA-468 triple-negative breast cancer cells
por: Borrego, Stacey L., et al.
Publicado: (2021)

Hypoxia-induced reactive oxygen species mediate N-cadherin and SERPINE1 expression, EGFR signalling and motility in MDA-MB-468 breast cancer cells
por: Azimi, Iman, et al.
Publicado: (2017)

Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors
por: Rousseau, Caroline, et al.
Publicado: (2011)

Formononetin Enhances the Tumoricidal Effect of Everolimus in Breast Cancer MDA-MB-468 Cells by Suppressing the mTOR Pathway
por: Zhou, Qianmei, et al.
Publicado: (2019)

S100A7 enhances invasion of human breast cancer MDA-MB-468 cells through activation of nuclear factor-κB signaling
por: Liu, Huamin, et al.
Publicado: (2013)

Characterization of Triple-Negative Breast Cancer MDA-MB-231 Cell Spheroid Model
por: Huang, Zhaoming, et al.
Publicado: (2020)

EGFR Promotes the Development of Triple Negative Breast Cancer Through JAK/STAT3 Signaling
por: Song, Xiang, et al.
Publicado: (2020)

Evaluation of cytotoxic effects of several novel tetralin derivatives against Hela, MDA-MB-468, and MCF-7 cancer cells
por: Shafiee, Fateme, et al.
Publicado: (2012)

Pharmacological Inhibition of CDK8 in Triple-Negative Breast Cancer Cell Line MDA-MB-468 Increases E2F1 Protein, Induces Phosphorylation of STAT3 and Apoptosis
por: Spear, Jensen M., et al.
Publicado: (2020)

The Hydroalcoholic Extract of Matricaria chamomilla Suppresses Migration and Invasion of Human Breast Cancer MDA-MB-468 and MCF-7 Cell Lines
por: Nikseresht, Mohsen, et al.
Publicado: (2017)

The treatment role of Cyperus rotundus L. to triple-negative breast cancer cells
por: Wang, Fukai, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0eqnr9viumro39b42ihj05c475